Canada Spends Logo

Explorez notre analyse du budget 2026

Grant: Doctoral: Vanier Canada Graduate Scholarships

University of Guelph

$150,000.00

Investigating Unique Contributions of the ShcD Phosphotyrosine Adaptor Protein to Cell Signaling Circuitry and Brain Cancer.

EF 2009-10

Résumé
As the fundamental units of life, cells of the human body need to know basic information, like where they reside in a tissue or organ, what functions they should perform, and when they should divide. These instructions can be communicated through biochemical signaling pathways made up of proteins. When these pathways are activated at the right times in appropriate locations, they support the growth, development, and maintenance of the body. However, under the wrong circumstances, they can lead to the unwanted proliferation and movement of cells that characterize cancer. The objective of my work is to investigate the contributions of a specific protein, called ShcD, to cellular communication. My preliminary studies have demonstrated that this protein is present in the human brain, but becomes over-expressed in the serious cranial cancer, glioblastoma multiforme. This raises many intriguing questions about its potential significance in the condition. Specifically, I am interested in studying whether ShcD can serve as a molecular marker for brain cancers, to eventually provide physicians and patients with new criteria for classifying malignancies, making diagnoses, and determining disease prognosis. It is also of great interest to determine how the ShcD protein becomes involved in cancer. With this knowledge, there may be the potential to design targeted therapies for the treatment of the illness. As a final objective, I intend to analyze the characteristics and functional attributes of ShcD that distinguish it from other signaling proteins of the cell. This will answer fundamental questions about how cells send and receive unique messages, which in turn will be important to future medical research and pharmaceutical development. Overall, my investigations are poised to improve the diagnosis and treatment of brain tumours, while advancing the field of cell biology.
Programme
Doctoral: Vanier Canada Graduate Scholarships
Bénéficiaire
Emplacement
Ontario, Canada
Type de bénéficiaire
Academia
Type
Grant
Source
CIHR Funding Decisions Database

Tel que publié

Id
197460
Name
Wills Melanie
Region
Ontario
Country
Canada
Orgtype
Institution Paid; Research Institution
Instname2
Cancer Research
Theme2
Biomedical
Prcname2
Vanier Canada Graduate Scholarships CIHR
Projecttitle
Investigating Unique Contributions of the ShcD Phosphotyrosine Adaptor Protein to Cell Signaling Circuitry and Brain Cancer.
Programtype2
Studentship Programs
Orgnameinp2
University of Guelph
Cihramount2
$150,000
Cihrequipment2
$0
Programname2
Doctoral: Vanier Canada Graduate Scholarships
Keyworddelim
Biochemistry; Brain Cancer; Cell Biology; Cellular Wiring; Gene Expression Analysis; Growth Factor Signaling; Neurochemistry; Phosphotyrosine Adaptor Proteins; Receptor Tyrosine Kinases; Signal Transduction
Abstract
As the fundamental units of life, cells of the human body need to know basic information, like where they reside in a tissue or organ, what functions they should perform, and when they should divide. These instructions can be communicated through biochemical signaling pathways made up of proteins. When these pathways are activated at the right times in appropriate locations, they support the growth, development, and maintenance of the body. However, under the wrong circumstances, they can lead to the unwanted proliferation and movement of cells that characterize cancer. The objective of my work is to investigate the contributions of a specific protein, called ShcD, to cellular communication. My preliminary studies have demonstrated that this protein is present in the human brain, but becomes over-expressed in the serious cranial cancer, glioblastoma multiforme. This raises many intriguing questions about its potential significance in the condition. Specifically, I am interested in studying whether ShcD can serve as a molecular marker for brain cancers, to eventually provide physicians and patients with new criteria for classifying malignancies, making diagnoses, and determining disease prognosis. It is also of great interest to determine how the ShcD protein becomes involved in cancer. With this knowledge, there may be the potential to design targeted therapies for the treatment of the illness. As a final objective, I intend to analyze the characteristics and functional attributes of ShcD that distinguish it from other signaling proteins of the cell. This will answer fundamental questions about how cells send and receive unique messages, which in turn will be important to future medical research and pharmaceutical development. Overall, my investigations are poised to improve the diagnosis and treatment of brain tumours, while advancing the field of cell biology.
Competitiondate
200911
Approvedterm2
3 yrs 0 mth
Pinamesdelim
Wills, Melanie
Approvedterm
3 ans 0 mois
Cihrcontribution2
~ $150,000~ $0~